Constipation during Entecavir treatment in Chronic Hepatitis B patients: Two Cases Reports
Journal Title: Archives of Hepatitis Research - Year 2017, Vol 3, Issue 1
Abstract
Entecavir (ETV) is an oral nucleoside analog inhibitor of hepatitis B virus (HBV) DNA polymerase, which is widely used in patients with chronic hepatitis B (CHB). Despite the excellent safety data of this agent, the adverse events of headache, diarrhea, nausea and vomiting are recorded in the drug instruction of ETV. Here we report two CHB patients with ETV-associated constipation in whom symptom fully disappeared following ETV withdrawal.
Authors and Affiliations
Wang Meng-Lan, Zhang Dong-Mei, Chen En-Qiang
Keywords
Related Articles
- EP ID EP559394
- DOI 10.17352/ahr.000013
- Views 41
- Downloads 0
Hepatitis E: New Clinical and Public Health Problem on the Western World? Review
Until recently, the occurrence of Hepatitis E in the western hemisphere did not amount to a clinical concern, due to its benign and usually sub-clinical evolution, as opposed to Asia and Africa, where large epidemies wit...
Occupational Hazard (Hepatitis B & C)
Hepatitis B and C are considered as an important health hazard among health care workers (HCWs). These blood borne infections can be transmitted either from HCW to a patient or vice-versa. Both viruses are known to cause...
Hepatic histological comparison between Acute Self-limiting Hepatitis A and Hepatitis E
Background: Histological findings of the liver in acute liver injury are basically affected by degree of liver damage. However, the differences in liver histology between acute self-limiting hepatitis A (AH-A) and hepati...
Sarcoidosis-Lymphoma Syndrome presenting by severe Cholestatic Hepatitis
Severe cholestatic hepatitis is an uncommon presentation of either sarcoidosis or Hodgkin lymphoma. Sarcoidosis lymphoma syndrome is a rare disorder with sarcoidosis heralding the onset of lymphoma. Here we report a case...
Farnesoid X Receptor Agonist as a new treatment option for Non-Alcoholic Fatty Liver disease: A Review
Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of fatty liver, characterized by the accumulation of fat in the hepatocytes in the absence of alcohol consumption. The spectrum of th...